323 related articles for article (PubMed ID: 34634855)
1. Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.
Li A; Chan HP; Gan PXL; Liew MF; Wong WSF; Lim HF
Korean J Intern Med; 2021 Nov; 36(6):1305-1319. PubMed ID: 34634855
[TBL] [Abstract][Full Text] [Related]
2. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma.
Kitaguchi Y; Komatsu Y; Fujimoto K; Hanaoka M; Kubo K
Int J Chron Obstruct Pulmon Dis; 2012; 7():283-9. PubMed ID: 22589579
[TBL] [Abstract][Full Text] [Related]
3. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
Pignatti P; Visca D; Zappa M; Zampogna E; Saderi L; Sotgiu G; Centis R; Migliori GB; Spanevello A
BMC Pulm Med; 2024 May; 24(1):247. PubMed ID: 38764008
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic airway inflammation in COPD.
Saha S; Brightling CE
Int J Chron Obstruct Pulmon Dis; 2006; 1(1):39-47. PubMed ID: 18046901
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
Cheng SL; Lin CH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
[TBL] [Abstract][Full Text] [Related]
7. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
Kostikas K; Brindicci C; Patalano F
Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007
[TBL] [Abstract][Full Text] [Related]
8. Association between COPD exacerbations and lung function decline during maintenance therapy.
Kerkhof M; Voorham J; Dorinsky P; Cabrera C; Darken P; Kocks JW; Sadatsafavi M; Sin DD; Carter V; Price DB
Thorax; 2020 Sep; 75(9):744-753. PubMed ID: 32532852
[TBL] [Abstract][Full Text] [Related]
9. [Eosinophilic chronic obstructive pulmonary disease: A review].
Anaev EK
Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
[TBL] [Abstract][Full Text] [Related]
10. Eosinophils in COPD-Current Concepts and Clinical Implications.
Mycroft K; Krenke R; Górska K
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737
[TBL] [Abstract][Full Text] [Related]
11. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease.
Jo YS; Moon JY; Park YB; Kim YH; Um SJ; Kim WJ; Yoon HK; Yoo KH; Jung KS; Rhee CK
BMC Pulm Med; 2022 Mar; 22(1):91. PubMed ID: 35296272
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
15. Blood eosinophils in COPD: friend or foe?
Papaporfyriou A; Bakakos P; Hillas G; Papaioannou AI; Loukides S
Expert Rev Respir Med; 2022 Jan; 16(1):35-41. PubMed ID: 34821191
[TBL] [Abstract][Full Text] [Related]
16. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
[TBL] [Abstract][Full Text] [Related]
17. Burden of illness in blood eosinophilic phenotype COPD patients in New Zealand.
Shantakumar S; Ho YF; Beale J; Gribben B
Respir Investig; 2021 Jul; 59(4):487-497. PubMed ID: 33994346
[TBL] [Abstract][Full Text] [Related]
18. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids.
Martínez-García MÁ; Méndez R; Olveira C; Girón R; García-Clemente M; Máiz L; Sibila O; Golpe R; Rodríguez-Hermosa JL; Barreiro E; Prados C; Rodríguez-López J; Oscullo G; Labarca G; de la Rosa D
Chest; 2023 Sep; 164(3):606-613. PubMed ID: 37088355
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait.
David B; Bafadhel M; Koenderman L; De Soyza A
Thorax; 2021 Feb; 76(2):188-195. PubMed ID: 33122447
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre.
Demarche SF; Schleich FN; Henket MA; Paulus VA; Van Hees TJ; Louis RE
BMJ Open; 2017 Nov; 7(11):e018186. PubMed ID: 29183929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
